index

BioChina 2026

IPHASE e thabetse ho phatlalatsa seabo sa rona ho BIOCHINA 2026, se etsahalang ka Hlakubele 12–14. Ketsahalo ena ea pele e kopanya baetapele le baqapi ho pholletsa le indasteri ea biopharmaceutical, e fana ka sethala se setle sa ho fapanyetsana maikutlo le ho hlahloba tsoelopele ea morao-rao mabapi le ho sibolloa ha lithethefatsi le nts'etsopele.

Joaloka moetapele oa tlhahlobo ea lithethefatsi tsa in vitro, IPHASE e ikemiselitse ho fana ka litharollo tse phahameng - tsa boleng ba bioloji tse tšehetsang libaka tse ngata tsa lipatlisiso, ho kenyeletsoa in vitro pharmacokinetics (ADME), pharmacodynamics, toxicology (genetic toxicity), bioanalysis, le pathology (TCR). Potefolio ea rona e kenyelletsa li-enzyme tsa subcellular, lisele tsa mantlha, li-organoids, le lisele tsa tlhaho tse tsoang ho batho le liphoofolo tsa liteko.

Ka ho sebelisa theknoloji e tsoetseng pele joalo ka ho hlopha lisele, re ts'ehetsa lipatlisiso tsa morao-rao ho Cell and Gene Therapy (CGT) mme re fana ka lisebelisoa tse tšepahalang tse potlakisang boqapi ho pholletsa le phaephe ea ntlafatso ea lithethefatsi.

Haeba u ea BIOCHINA 2026, re ka thabela ho hokela, ho fapanyetsana lintlha, le ho hlahloba menyetla ea tšebelisano. Ke tla u bona moo!




Nako ea poso: 2026-03-11 11:00:21
  • E fetileng:
  • E latelang:
  • Khetho ea Puo